A Must-Attend for Clinical Research Professionals
Join the GCP team from the Therapeutic Goods Administration (TGA) and Dr. Tanya Symons, an internationally recognised GCP expert, for an insightful 90-minute webinar on the latest updates to ICH GCP.
In this webinar, we will:
- Set expectations regarding the TGA’s process of adopting the updated guidelines, including sector consultation and estimated timelines.
- Give an overview of the critical changes to ICH GCP E6 R3.
- Demystify new concepts, such as Quality by Design.
- Discuss practical guidance on implementing a flexible and efficient approach to GCP.
- Provide ample Q&A time to address your questions.
This session is designed for anyone seeking to understand the updated ICH-GCP E6 R3 guidelines. The revisions in R3 will impact all professionals working in the clinical research industry.
About the presenter - Dr Tanya Symons
Dr. Tanya Symons is a highly experienced clinical trial trainer and consultant, both in Australia and internationally. She has delivered GCP, clinical trial and ethics training to over 90,000 people.
In 2012, Tanya redeveloped and continues to write the content for the UK's NIHR Clinical Trials Toolkit. In Australia, she works with governments, government-funded organisations and trial sponsors to ensure that trial initiatives align with international best practices. She has authored or co-authored several national guidelines, including the TGA Australian Clinical Trials Handbook, the NHMRC Safety Reporting and Serious Breach Guidelines and the ACTA/CTIQ Consumer Involvement and Engagement Toolkit. Tanya also led a joint ACTA/ARCs project to provide national feedback on the draft ICH E6 R3 Guidelines.